Pharm Ophthalmic I Flashcards
most common route administration ocular drugs
topical
locations for local injections in eye
subconjunctiva; retrobulbar sub tenons intracameral (ant chamber) intravitreal
what barriers keep eye separated from systemic access
blood-retina
blood-aqueous
blood-vitreous
rate and extent of absorption for topical eye drugs
determined by time in the cul de sac and precorneal tear film
elimination by nasolacrimal drainage
drug binding to tear proteins
drug metabolis by tear and tissue protesins
diffusion across cornea and conjuctiva
what is reason for systemic complications of topical drugs used chronically
absorption from nasal mucosa avoiding first pass metabolism in liver
what are the desired routes for localized ocular effects
transcorneal and transconjunctiva/scleral absorption
type of drug best suited for transcorneal absorption and why
hydrophilic and hydrophobic
trilamellar
pro drug for epinephrine
dipivefrin hydrochloride
pro drug for PG F2alpha
latanoprost
what metabolizes the prod drugs given to eye
esterases
topically applied ocular drugs are eliminated how after systemic absorption
liver and kidney
what type of drug class can affect iris sphincter muscle that constricts pupils
PAN stimulation or inhibition
what is miosis
mydriasis
miosis is small pupils
mydriasis is large pupils
what type of drug class can affect the iris dilator muscle
sympathetic activaiton
what type of drug class can affect ciliary muscle
SAN activation
PAN activation
PAN inhibition
What is anisocoria
inequality of pupils
Horners syndrome
injury to SAN
ptosis
miosis
anhydrosis
third CN injury
ptosis
mydriasis!
Adies pupil
injury to PAN tract
mydriasis
loss of DTR
excessive sweating